Advocacy intelligence hub — real-time data for patient organizations
Pierre Fabre Medicament
EspeRare Foundation — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Dorothy K Grange, MD, MD
Washington University School of Medicine
📍 SAINT LOUIS, MO
Holm Schneider, MD
University Hospital Erlangen
Ignatia B Van den Veyver, MD
Baylor College of Medicine
Amy Paller, MD, MD
Northwestern University Department of Dermatology
📍 CHICAGO, IL
Kenneth Huttner, MD, PhD, M.D
Edimer Pharmaceuticals
📍 WALTHAM, MA
Steven Isakoff, MD, PhD, MD PhD
Massachusetts General Hospital
📍 BOSTON, MA